$14.62
1.3510.17%
At close: -
$14.40
-0.22-1.50%
After Hours: Jun 18, 6:35 PM EDT
Comments
Loading...
Latest Crescent Biopharma Stock News | NASDAQ:CBIO | Benzinga
Get the latest news on Crescent Biopharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Crescent Biopharma performance
Categories: All
Wednesday, June 18, 2025
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- LifeSci Capital Initiates Coverage On Crescen...
- US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity
- Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
Monday, October 30, 2023
Wednesday, October 25, 2023
Monday, October 23, 2023
Friday, October 20, 2023
Monday, October 16, 2023
Friday, October 13, 2023
Tuesday, September 05, 2023
Monday, September 04, 2023
Friday, September 01, 2023
Friday, August 25, 2023
Thursday, August 17, 2023
Wednesday, August 16, 2023
Monday, August 14, 2023
Thursday, July 20, 2023
Thursday, June 22, 2023
Wednesday, June 21, 2023
Tuesday, March 21, 2023
Wednesday, March 15, 2023
Thursday, March 09, 2023
Tuesday, March 07, 2023
Friday, March 03, 2023
Wednesday, March 01, 2023
Tuesday, February 28, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Catalyst Biosciences Shares Are Rallying: What's Driving The Action?
- Catalyst Biosciences shares are trading highe...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
- Reported Late Monday Feb.27, South Korea's GC Biopharma, Announced Today That It Has Signed An Asset Purchase Agreement With Catalyst Biosciences To Acquire 3 Programs Related To The Orphan Hematology Disorders; No Financial Terms Disclosed
